HEALTH After judge orders hospital to use experimental Covid-19 treatment, woman recovers

Green Co.

Administrator
_______________

Ajudge ordered Millard Fillmore Suburban Hospital last week to give a Covid-19 patient an experimental treatment, and her family and attorneys say they believe that saved 80-year-old Judith Smentkiewicz's life.

The drug Ivermectin – a pill sometimes used to treat children with head lice or to rid dogs and cats of worms – is not yet approved by the federal government for use against Covid-19. But Smentkiewicz's son and daughter call it “a miracle drug” in their court papers.
So do her attorneys, Ralph C. Lorigo and Jon F. Minear.

“This lady was on a ventilator, literally on her deathbed, before she was given this drug,” Lorigo told The Buffalo News about Smentkiewicz, a Cheektowaga resident. “As far as we’re concerned, the judge’s order saved this woman’s life.”

Lorigo said one doctor at the hospital allowed the patient to be given the drug, but after she had been given one dose, another doctor at the hospital refused to allow further doses. He said family members went to court to force the hospital to resume treatment with Ivermectin. State Supreme Court Judge Henry J. Nowak sided with them.

Dr. Thomas A. Russo, one of the region’s leading experts on infectious diseases, said he was glad to hear that Smentkiewicz is doing better, but he said people should never jump to conclusions about Ivermectin or any other drug based on one patient’s outcome.

“There are some indications that this drug may have some merit in treating Covid-19 ... Yes, it is possible that it helped this woman,” Russo said. “But the trials and testing are ongoing. We don’t have definitive data yet to show it does help. Presently, it is not recommended as a treatment for Covid-19.”

Russo is the chief of infectious diseases at the University at Buffalo's Jacobs School of Medicine and Biomedical Sciences. He has no involvement in the Smentkiewicz case.

The patient’s son, Michael Smentkiewicz, said hospital officials had told him and his sister, Michelle Kulbacki, on Dec. 31 that their mother’s chance of survival – as an 80-year-old Covid-19 patient on a ventilator – was about 20%.

He said doctors at the hospital also told the family that Smentkiewicz would probably be on a ventilator in the Intensive Care Unit for at least a month.

“We did a lot of our own research, we read about Ivermectin ... The results sounded very promising, and we decided we had to try something different,” Michael Smentkiewicz said. “We pressured the doctor in the ICU to give it to her. He finally agreed.”
On Jan. 2, Smentkiewicz was given her first dose of Ivermectin, and according to court papers filed by her family, she made “a complete turnaround.”

“In less than 48 hours, my mother was taken off the ventilator, transferred out of the Intensive Care Unit, sitting up on her own and communicating,” Kulbacki said in a court affidavit.

But after her mother was transferred to another hospital wing away from the ICU, doctors in that unit refused to give her any more doses of the drug, and her condition quickly declined, the family said in court papers.

“We were astounded when they refused to give her any more doses,” Michael Smentkiewicz said. “That’s why I called Ralph Lorigo and we took the hospital to court.”

Kaleida Health, which operates the hospital, opposed the family’s request in court. Lorigo said Kaleida attorney Michael J. Roach argued to Judge Nowak that doctors – and not the courts – should be making decisions about medical care.
On Jan. 8, Nowak ordered the hospital to “immediately administer the drug Ivermectin” to Smentkiewicz, court papers show.

“But the judge also told us verbally that Judith’s family doctor would have to write a prescription for Ivermectin, which he did,” Lorigo said. “In 46 years as an attorney, I’ve never seen another case where a family had to get a court order to continue a treatment that had already been started by a hospital.”

Michael P. Hughes, spokesman and chief of staff for Kaleida Health, said the health care company is "aware of this family’s position," but he declined to discuss details because of federal privacy laws and because the case has become "a legal matter."

Roach, the hospital attorney, declined to comment, telling a reporter to call Hughes.

Michael Smentkiewicz said Thursday that his mother’s condition has improved again since the Ivermectin treatments resumed.
“She called me (Wednesday) night. Her voice was raspy, but it was so exciting to hear her voice,” he said. “She is sitting up in bed. She’s off the ventilator, but she has a canula in her nose, providing supplemental oxygen.”

He added that a doctor from the hospital told him Thursday that his mother appears to have "turned the corner" in her fight against the virus.

Michael Smentkiewicz said he also believes the power of prayer helped his mother.

“We have not been able to see her since she was taken to the hospital by ambulance on December 29, and that has been hard on all of us,” he said. “Family flew in from all over the country to be here. On New Year’s Eve, about eight of us held a little prayer service for her, out in the hospital parking lot. Even though we couldn’t be with her, we felt that it was important to be on that property, praying for her.”


Ivermectin has some passionate supporters in the medical field, but the U.S. Food & Drug Administration says the drug has not yet been approved for use in this country as a Covid-19 treatment.


“While there are approved uses for Ivermectin in people and animals, it is not approved for the prevention or treatment of Covid-19,” the federal agency says on its website. “You should not take any medicine to treat or prevent Covid-19 unless it has been prescribed to you by your health care provider and acquired from a legitimate source … Additional testing is needed to determine whether Ivermectin might be appropriate to prevent or treat coronavirus or Covid-19.”

Some doctors feel the government should move much more quickly to approve Ivermectin as a treatment for the virus that has killed nearly 400,000 Americans.

Dr. Pierre Kory, who heads an association of critical care doctors, testified before Congress in December, asking federal agencies to prevent "needless deaths" by speeding up its testing and research on Ivermectin.

Smentkiewicz's family describes her as an "amazing woman," a retired secretary who raised two children as a single mother. They said she still works five days a week, cleaning houses.

Russo, who urges caution until the government gets more data about Ivermectin, said he “absolutely” understands why Smentkiewicz’s family was so insistent that Kaleida doctors give her the drug.

“I think we all can understand where this family was coming from,” Russo said. “From their point of view, desperate times call for desperate measures.”
 

Kris Gandillon

The Other Curmudgeon
_______________
Ivermectin is a recognized treatment now.

 

Thinwater

Firearms Manufacturer
Way to many doctors have the "Not invented here" attitude. They think of themselves as the smartest person alive and if they did not invent it , it must not be any good.

Its the Dr version of "REspect MY aUthority" attitude held by some cops.
 

Krayola

Veteran Member
Way to many doctors have the "Not invented here" attitude. They think of themselves as the smartest person alive and if they did not invent it , it must not be any good.

Its the Dr version of "REspect MY aUthority" attitude held by some cops.
Absolutely. I think the doctor was pissed that they dared to question his decisions and that made him dig his heels in even further.
 

steve graham

Veteran Member

Ajudge ordered Millard Fillmore Suburban Hospital last week to give a Covid-19 patient an experimental treatment, and her family and attorneys say they believe that saved 80-year-old Judith Smentkiewicz's life.

The drug Ivermectin – a pill sometimes used to treat children with head lice or to rid dogs and cats of worms – is not yet approved by the federal government for use against Covid-19. But Smentkiewicz's son and daughter call it “a miracle drug” in their court papers.
So do her attorneys, Ralph C. Lorigo and Jon F. Minear.

“This lady was on a ventilator, literally on her deathbed, before she was given this drug,” Lorigo told The Buffalo News about Smentkiewicz, a Cheektowaga resident. “As far as we’re concerned, the judge’s order saved this woman’s life.”

Lorigo said one doctor at the hospital allowed the patient to be given the drug, but after she had been given one dose, another doctor at the hospital refused to allow further doses. He said family members went to court to force the hospital to resume treatment with Ivermectin. State Supreme Court Judge Henry J. Nowak sided with them.

Dr. Thomas A. Russo, one of the region’s leading experts on infectious diseases, said he was glad to hear that Smentkiewicz is doing better, but he said people should never jump to conclusions about Ivermectin or any other drug based on one patient’s outcome.

“There are some indications that this drug may have some merit in treating Covid-19 ... Yes, it is possible that it helped this woman,” Russo said. “But the trials and testing are ongoing. We don’t have definitive data yet to show it does help. Presently, it is not recommended as a treatment for Covid-19.”

Russo is the chief of infectious diseases at the University at Buffalo's Jacobs School of Medicine and Biomedical Sciences. He has no involvement in the Smentkiewicz case.

The patient’s son, Michael Smentkiewicz, said hospital officials had told him and his sister, Michelle Kulbacki, on Dec. 31 that their mother’s chance of survival – as an 80-year-old Covid-19 patient on a ventilator – was about 20%.

He said doctors at the hospital also told the family that Smentkiewicz would probably be on a ventilator in the Intensive Care Unit for at least a month.

“We did a lot of our own research, we read about Ivermectin ... The results sounded very promising, and we decided we had to try something different,” Michael Smentkiewicz said. “We pressured the doctor in the ICU to give it to her. He finally agreed.”
On Jan. 2, Smentkiewicz was given her first dose of Ivermectin, and according to court papers filed by her family, she made “a complete turnaround.”

“In less than 48 hours, my mother was taken off the ventilator, transferred out of the Intensive Care Unit, sitting up on her own and communicating,” Kulbacki said in a court affidavit.

But after her mother was transferred to another hospital wing away from the ICU, doctors in that unit refused to give her any more doses of the drug, and her condition quickly declined, the family said in court papers.

“We were astounded when they refused to give her any more doses,” Michael Smentkiewicz said. “That’s why I called Ralph Lorigo and we took the hospital to court.”

Kaleida Health, which operates the hospital, opposed the family’s request in court. Lorigo said Kaleida attorney Michael J. Roach argued to Judge Nowak that doctors – and not the courts – should be making decisions about medical care.
On Jan. 8, Nowak ordered the hospital to “immediately administer the drug Ivermectin” to Smentkiewicz, court papers show.

“But the judge also told us verbally that Judith’s family doctor would have to write a prescription for Ivermectin, which he did,” Lorigo said. “In 46 years as an attorney, I’ve never seen another case where a family had to get a court order to continue a treatment that had already been started by a hospital.”

Michael P. Hughes, spokesman and chief of staff for Kaleida Health, said the health care company is "aware of this family’s position," but he declined to discuss details because of federal privacy laws and because the case has become "a legal matter."

Roach, the hospital attorney, declined to comment, telling a reporter to call Hughes.

Michael Smentkiewicz said Thursday that his mother’s condition has improved again since the Ivermectin treatments resumed.
“She called me (Wednesday) night. Her voice was raspy, but it was so exciting to hear her voice,” he said. “She is sitting up in bed. She’s off the ventilator, but she has a canula in her nose, providing supplemental oxygen.”

He added that a doctor from the hospital told him Thursday that his mother appears to have "turned the corner" in her fight against the virus.

Michael Smentkiewicz said he also believes the power of prayer helped his mother.

“We have not been able to see her since she was taken to the hospital by ambulance on December 29, and that has been hard on all of us,” he said. “Family flew in from all over the country to be here. On New Year’s Eve, about eight of us held a little prayer service for her, out in the hospital parking lot. Even though we couldn’t be with her, we felt that it was important to be on that property, praying for her.”


Ivermectin has some passionate supporters in the medical field, but the U.S. Food & Drug Administration says the drug has not yet been approved for use in this country as a Covid-19 treatment.


“While there are approved uses for Ivermectin in people and animals, it is not approved for the prevention or treatment of Covid-19,” the federal agency says on its website. “You should not take any medicine to treat or prevent Covid-19 unless it has been prescribed to you by your health care provider and acquired from a legitimate source … Additional testing is needed to determine whether Ivermectin might be appropriate to prevent or treat coronavirus or Covid-19.”

Some doctors feel the government should move much more quickly to approve Ivermectin as a treatment for the virus that has killed nearly 400,000 Americans.

Dr. Pierre Kory, who heads an association of critical care doctors, testified before Congress in December, asking federal agencies to prevent "needless deaths" by speeding up its testing and research on Ivermectin.

Smentkiewicz's family describes her as an "amazing woman," a retired secretary who raised two children as a single mother. They said she still works five days a week, cleaning houses.

Russo, who urges caution until the government gets more data about Ivermectin, said he “absolutely” understands why Smentkiewicz’s family was so insistent that Kaleida doctors give her the drug.

“I think we all can understand where this family was coming from,” Russo said. “From their point of view, desperate times call for desperate measures.”
Ivermectin is NOT a "desperate" measure! These doctors make me sick!
 

Southside

Has No Life - Lives on TB
The doctors and the system are trying to hold on the money line.
They care less about the patient.

Southside
 

paul bunyan

Frostbite Falls, Minnesota
The crack in the dam is now visible.

How many Licensed Medical Practitioners will be sued or die after the public learns that a miracle therapy has been available and their loved ones were refused its use... and died, alone, on a ventilator.

Ignorance or Large pharmaceutical interference????
 

paul bunyan

Frostbite Falls, Minnesota
Review ARTICLE

Front. Pharmacol. | doi: 10.3389/fphar.2021.643369

Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19 Provisionally accepted The final, formatted version of the article will be published soon. Notify me
 Pierre Kory1*, G U. Meduri2, 3,  Jose Iglesias4, Joseph Varon5, Keith Berkowitz6, Howard Kornfeld7,  Eivind Vinjevoll8, Scott Mitchell9, Fred Wagshul10 and  Paul E. Marik11

  • 1Other, United States
  • 2Memphis VA Medical Center (VHA), United States
  • 3University of Tennessee Health Science Center (UTHSC), United States
  • 4Hackensack Meridian School of Medicine, Seton Hall University, United States
  • 5University of Texas Health Science Center, United States
  • 6Center for Balanced Health, United States
  • 7Other, United States
  • 8Molde Hospital, Norway
  • 9Princess Elizabeth Hospital, Guernsey
  • 10Lung Center of America, United States
  • 11Eastern Virginia Medical School, United States

In March 2020, the Front Line COVID-19 Critical Care Alliance (FLCCC) was created and led by
Professor Paul E. Marik to continuously review the rapidly emerging basic science, translational, and clinical data to develop a treatment protocol for COVID-19. The FLCCC then recently discovered that ivermectin, an anti-parasitic medicine, has highly potent anti-viral and anti-inflammatory properties against COVID-19. They then identified repeated, consistent, large magnitude improvements in clinical outcomes in multiple, large, randomized and observational controlled trials in both prophylaxis and treatment of COVID-19. Further, data showing impacts on population wide health outcomes have resulted from multiple, large “natural experiments” that occurred when various city mayors and regional health ministries within South American countries initiated “ivermectin distribution” campaigns to their citizen populations in the hopes the drug would prove effective. The tight, reproducible, temporally associated decreases in case counts and case fatality rates in each of those regions compared to nearby regions without such campaigns, suggest that ivermectin may prove to be a global solution to the pandemic. This was further evidenced by the recent incorporation of ivermectin as a prophylaxis and treatment agent for COVID-19 in the national treatment guidelines of Belize, Macedonia, and the state of Uttar Pradesh in Northern India, populated by 210 million people. To our knowledge, the current review is the earliest to compile sufficient clinical data to demonstrate the strong signal of therapeutic efficacy as it is based on numerous clinical trials in multiple disease phases. One limitation is that half the controlled trials have been published in peer-reviewed publications, with the remainder taken from manuscripts uploaded to medicine pre-print servers. Although it is now standard practice for trials data from pre-print servers to immediately influence therapeutic practices during the pandemic, given the controversial therapeutics adopted as a result of this practice, the FLCCC argues that it is imperative that our major national and international health care agencies devote the necessary resources to more quickly validate these studies and confirm the major, positive epidemiological impacts that have been recorded when ivermectin is widely distributed among populations with a high incidence of COVID-19 infections.





Keywords: Ivermectin, COVID-19, Infectious Disease, pulmonary infection, respiratory failure

Received: 18 Dec 2020; Accepted: 13 Jan 2021.

Copyright: © 2021 Kory, Meduri, Iglesias, Varon, Berkowitz, Kornfeld, Vinjevoll, Mitchell, Wagshul and Marik. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: MD. Pierre Kory, Other, Madison, WI, United States, pierrekory@icloud.com
 

Green Co.

Administrator
_______________
I did a lot of reading before convincing myself to use it as a preventative. Many papers/studies also show ivermectin to be a good preventative against other corona viruses, such as the common cold and flu. Is it possible that a common cheap veterinary medicine could become a go to for prevention, rather than vaccines? I know I'm not taking that new shot.
 

Bad Hand

Veteran Member
We are not supposed the jump on the ivermectin because of one woman's out come but we are supposed to jump on the COVID vaccine which is killing people and causing serious side effects.
 
Top